好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

2016 Annual Meeting | Future Directions and Challenges in Stroke Team Action Therapy (STAT)

Monday 04/18/16
01:00 PM - 05:30 PM Add To Calendar
This program will be presented both in-person and online
This program is not expected to be available in the meeting's On Demand product.
Integrated Neuroscience
Joseph P. Broderick, MD, FAAN, Jeffrey L. Saver, MD, FAAN
Cerebrovascular Disease and Interventional Neurology
0.00 credit
Event Timeline
01:00 PM - 01:10 PM Introduction
01:00 PM - 05:30 PM Abstract 001 - Gaze Deviation and Acute Stroke Care Strategies
01:00 PM - 05:30 PM Abstract 002 - Comparison of Large Vessel Occlusion Prediction Scores
Toby I. Gropen, MD
01:00 PM - 05:30 PM Abstract 003 - Variability in Approach to Treatment of Acute Central Retinal Artery Occlusion in US Teaching Hospitals
Matthew Schrag, MD
01:00 PM - 05:30 PM Abstract 004 - Intracranial Hemorrhage on Warfarin: Time to Reversal Is of the Essence
Chandan B. Mehta, MD
01:00 PM - 05:30 PM Abstract 005 - Time is Brain: Standardized Neuro-Interventional Thrombectomy Protocols lead to Faster Recanalization Times
01:00 PM - 05:30 PM Abstract 006 - Effect of Annual Hospital Procedure Volume on Outcomes after Mechanical Thrombectomy in Acute Ischemic Stroke Patients: An Analysis of 13,502 Procedures
Achint A. Patel
01:00 PM - 05:30 PM Abstract 007 - Arterial Recanalization in the Golden Hour of IV tPA Administration for Ischemic Stroke
Rodica Di Lorenzo, MD
01:00 PM - 05:30 PM Abstract 008 - ARTSS-2: Final Results of a Pilot, Phase IIb, Randomized, Multi-Center Trial of Argatroban in Combination with Recombinant Tissue Plasminogen Activator for Acute Stroke
Andrew D. Barreto, MD
01:00 PM - 05:30 PM Abstract 009 - Early CT Changes in Patients Admitted for Thrombectomy: Intra- and Interrater Agreement and Systematic Review of the Literature
Naim N. Khoury, MD, MS
01:00 PM - 05:30 PM Abstract 010 - Onset to Reperfusion Times Strongly Determine Clinical Outcome Across a Wide Range of ASPECTS Scores in Endovascular Ischemic Stroke Therapy
01:00 PM - 05:30 PM Abstract 011 - Overcoming Barriers to Reduce Door to Needle Times in Acute Ischemic Stroke Patients: Field to CT
Spozhmy Panezai, MD
01:00 PM - 05:30 PM Abstract 012 - Symptomatic Cerebral Ischemia Associated with Intensive Blood Pressure Lowering Following Acute Intracerebral Hemorrhage
Natalie Organek, MD
01:00 PM - 05:30 PM Abstract 013 - The DRAGON Score Predicts Functional Outcomes in Acute Ischemic Stroke Patients Receiving both Intravenous Tissue Plasminogen Activator (IVtPA) and Endovascular Therapy
Noorie Pednekar, MD
01:10 PM - 01:45 PM The STAT Ambulance in Motion: Should My Center Get One?
James C. Grotta, MD, FAAN
02:05 PM - 02:40 PM New Developments in Acute Stroke Neuroimaging: Future Directions
Gregory W. Albers, MD
03:00 PM - 03:30 PM Break/Guided Poster Rounds
03:30 PM - 04:05 PM Mechanical Thrombectomy Devices: How Many Are There and Where Are We Going?
Johanna T. Fifi, MD, FAAN
04:25 PM - 05:00 PM Minimizing Geographical Disparities in Acute Stroke Treatment
Dawn O. Kleindorfer, MD, FAAN
05:20 PM - 05:30 PM Conclusion
Faculty Disclosures
Johanna T. Fifi, MD, FAAN Dr. Fifi has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Stryker, Inc. Dr. Fifi has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Microvention. Dr. Fifi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cerenovus. Dr. Fifi has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Medtronic. Dr. Fifi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Serenity. Dr. Fifi has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for MIVI. Dr. Fifi has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Heart Association. Dr. Fifi has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Various law firms. Dr. Fifi has stock in Endostream. Dr. Fifi has stock in Synchron. Dr. Fifi has stock in Imperative Care. Dr. Fifi has stock in Truvic. Dr. Fifi has stock in Bendit. Dr. Fifi has stock in Cerebrotech. Dr. Fifi has stock in Sim&Cure. Dr. Fifi has stock in Q'Apel. The institution of Dr. Fifi has received research support from Viz AI.
Gregory W. Albers, MD No disclosure on file
Dawn O. Kleindorfer, MD, FAAN Dr. Kleindorfer has nothing to disclose.
Joseph P. Broderick, MD, FAAN Dr. Broderick has received publishing royalties from a publication relating to health care.
Jeffrey L. Saver, MD, FAAN Dr. Saver has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Medtronic. Dr. Saver has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Stryker. Dr. Saver has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cerenovus. Dr. Saver has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Boehringer Ingelheim (prevention only). Dr. Saver has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Medical Association. Dr. Saver has received stock or an ownership interest from Rapid Medical.
Natalia S. Rost, MD, MPH, FAAN, FAHA Dr. Rost has received personal compensation in the range of $50,000-$99,999 for serving as an officer or member of the Board of Directors for 好色先生. Dr. Rost has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Stroke - AHA/ASA Journal. The institution of Dr. Rost has received research support from NIH. Dr. Rost has received publishing royalties from a publication relating to health care.
James C. Grotta, MD, FAAN Dr. Grotta has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Frazer Ltd. Dr. Grotta has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Haemonetics. Dr. Grotta has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Acticor. Dr. Grotta has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Prolong Pharma. Dr. Grotta has received publishing royalties from a publication relating to health care. Dr. Grotta has received publishing royalties from a publication relating to health care.
Panayiotis N. Varelas, MD, PhD, FAAN Dr. Varelas has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB. Dr. Varelas has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Astra Zeneca -Alexion - Portola. Dr. Varelas has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. Varelas has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Astra Zeneca- Alexion-Portola. Dr. Varelas has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Marinus. Dr. Varelas has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for UCB. The institution of Dr. Varelas has received research support from Marinus. The institution of Dr. Varelas has received research support from Bayer. Dr. Varelas has received publishing royalties from a publication relating to health care. An immediate family member of Dr. Varelas has received personal compensation in the range of $5,000-$9,999 for serving as a Rep to the RUC meeting with AAN. Dr. Varelas has received personal compensation in the range of $500-$4,999 for serving as a Speaker at the Annual Meeting with AAN. Dr. Varelas has a non-compensated relationship as a President - Past President with Neurocritical Care Society that is relevant to AAN interests or activities.
Patrick J. Lavin, MB, BCh Dr. Lavin has nothing to disclose.
Mohammed Rehman, DO Dr. Rehman has nothing to disclose.
Stephen J. Marks, MD No disclosure on file
Sheryl Martin-Schild, MD, PhD, FAAN No disclosure on file
Steven Levine, MD, FAHA Dr. Levine has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for MEDLINK. Dr. Levine has received personal compensation in the range of $50,000-$99,999 for serving as an Expert Witness for Law Firms. The institution of Dr. Levine has received research support from NIH.
Howard S. Kirshner, MD, FAAN No disclosure on file
Megan Donohue, MD No disclosure on file
Toby I. Gropen, MD Dr. Gropen has nothing to disclose.
Andrew D. Barreto, MD No disclosure on file
Ethan Brandler No disclosure on file
No disclosure on file
Ramesh Madhavan, MD, FAAN Dr. Madhavan has received stock or an ownership interest from TiaTech USA and TiaTech India. Dr. Madhavan has received intellectual property interests from a discovery or technology relating to health care.
Sylvain Lanthier, MD Dr. Lanthier has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BMS-Pfizer Alliance. Dr. Lanthier has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Servier. Dr. Lanthier has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for BMS-Pfizer Alliance. Dr. Lanthier has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Servier.
Muhammad S. Hussain, MD Dr. Hussain has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cerenovus. Dr. Hussain has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Tiger Medical.
Karen C. Albright, DO, DO, PhD, MS, MPH Dr. Albright has nothing to disclose.
Nazli A. Janjua, MD, MBBS Dr. Janjua has nothing to disclose.
Ken Uchino, MD Dr. Uchino has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Aboott Laboratories, Inc.. Dr. Uchino has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for ACP JOURNAL CLUB. The institution of Dr. Uchino has received research support from NIH.
Joseph L. Schindler, MD Dr. Schindler has received personal compensation for serving as an employee of Aeromics. Dr. Schindler has received personal compensation in the range of $50,000-$99,999 for serving as an officer or member of the Board of Directors for Aeromics. Dr. Schindler has received stock or an ownership interest from Aeromics. Dr. Schindler has received publishing royalties from a publication relating to health care.
David M. Greer, MD, FAAN Dr. Greer has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Thieme, Inc. Dr. Greer has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for multiple. The institution of Dr. Greer has received research support from Becton, Dickinson and Company. Dr. Greer has received publishing royalties from a publication relating to health care. Dr. Greer has received publishing royalties from a publication relating to health care.
David S. Liebeskind, MD, FAAN Dr. Liebeskind has received research support from Cerenovus. Dr. Liebeskind has received research support from Genentech . Dr. Liebeskind has received research support from Medtronic. Dr. Liebeskind has received research support from Stryker.
Mauricio Ruiz Cuero, MD No disclosure on file
Mohammad Moussavi, MD Dr. Moussavi has nothing to disclose.
Jawad F. Kirmani, MD Dr. Kirmani has nothing to disclose.
Naim N. Khoury, MD, MS Dr. Khoury has nothing to disclose.
Alexandre Y. Poppe, MD The institution of Dr. Poppe has received research support from Stryker. The institution of Dr. Poppe has received research support from Servier.
Amelia K. Boehme, PhD Dr. Boehme has nothing to disclose.
Panayiotis Mitsias, MD Dr. Mitsias has nothing to disclose.
Morgan J. Patrylo, MD No disclosure on file
Spozhmy Panezai, MD Dr. Panezai has nothing to disclose.
Florence Chukwuneke, RN No disclosure on file
Hayet Boudjani, MD Dr. Boudjani has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen . Dr. Boudjani has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion.
Dolora R. Wisco, MD Dr. Wisco has nothing to disclose.
Seby John, MD Dr. John has nothing to disclose.
Ramandeep Sahni, MD Dr. Sahni has nothing to disclose.
Pratik D. Bhattacharya, MD, MPH Dr. Bhattacharya has a non-compensated relationship as a Research Advisor with Defeat MSA Alliance 501 (c) (3) that is relevant to AAN interests or activities.
Jin Li, MD, PhD, FAAN Dr. Li has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Abbvie. Dr. Li has a non-compensated relationship as a member, woman leadership committee with AAN that is relevant to AAN interests or activities.
Teddy S. Youn, MD Dr. Youn has nothing to disclose.
Nicole Daneault, MD No disclosure on file
Andre Durocher, MD No disclosure on file
Sanjeeva R. Onteddu, MD, FAAN Dr. Onteddu has nothing to disclose.
Emiliya Melkumova, MD Dr. Melkumova has nothing to disclose.
Natalie Organek, MD No disclosure on file
Lauren S. Feldman, DO No disclosure on file
Sonal Mehta, MD Dr. Mehta has nothing to disclose.
Akira Todo, MD No disclosure on file
Sammy D. Pishanidar, MD No disclosure on file
Siddhart K. Mehta, MD Dr. Mehta has nothing to disclose.
Jaskiran Brar, MD No disclosure on file
Vitor Pereira-Mendes No disclosure on file
Rodica Di Lorenzo, MD Dr. Di Lorenzo has nothing to disclose.
Mathew Jones, PharmD, BCPS No disclosure on file
Chandan B. Mehta, MD Dr. Mehta has nothing to disclose.
Matthew Schrag, MD No disclosure on file
Parvinder Kaur, MD No disclosure on file
Harshil Shah, Jr., MBBS No disclosure on file
Alyana Samai No disclosure on file
Brian T. Perrin, MD No disclosure on file
Daniel Korya, MD No disclosure on file
Joshua N. Daniel, MD No disclosure on file
Kristin Salottolo, MPH Ms. Salottolo has nothing to disclose.
Noorie Pednekar, MD No disclosure on file
Abhishek Lunagariya, MD No disclosure on file
Achint A. Patel No disclosure on file
David Bar-Or David Bar-Or has received intellectual property interests from a discovery or technology relating to health care.